Therapeutic Asset Ratings

cgt6297

cirtociclib

Ctim-76

Ctx-10726

Dat-2645

dr-0202

Drug Product De-Til-0255

hh160

Hwk-007

Hwk-016, Mucin-16-Targeted Adc

Ide-161

Imlunestrant

Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide

IPH5301

Lncb74

lyl797

MGC026

Moma-341

mov18 ige

Naptumomab Estafenatox

nkt3447

nm32-2668

Nrm-823

NT-112

Obinutuzumab